ZELTIQ Aesthetics, Inc. (ZLTQ) Rating Lowered to Neutral at Piper Jaffray Companies

ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ) was downgraded by investment analysts at Piper Jaffray Companies from an “overweight” rating to a “neutral” rating in a research note issued on Monday.

ZLTQ has been the topic of a number of other reports. Aegis assumed coverage on shares of ZELTIQ Aesthetics in a report on Wednesday, December 7th. They set a “buy” rating and a $51.00 target price on the stock. Zacks Investment Research raised shares of ZELTIQ Aesthetics from a “hold” rating to a “buy” rating and set a $41.00 price objective on the stock in a research note on Wednesday, October 26th. Brean Capital reaffirmed a “buy” rating on shares of ZELTIQ Aesthetics in a research note on Monday, October 24th. Maxim Group upped their price objective on shares of ZELTIQ Aesthetics from $48.00 to $58.00 and gave the company a “buy” rating in a research note on Wednesday, January 4th. Finally, Northcoast Research reaffirmed a “buy” rating on shares of ZELTIQ Aesthetics in a research note on Tuesday, November 8th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock. ZELTIQ Aesthetics has a consensus rating of “Hold” and a consensus price target of $44.60.

Analyst Recommendations for ZELTIQ Aesthetics (NASDAQ:ZLTQ)

Shares of ZELTIQ Aesthetics (NASDAQ:ZLTQ) opened at 55.61 on Monday. The company’s 50 day moving average is $44.20 and its 200-day moving average is $40.37. The firm has a market capitalization of $2.22 billion, a price-to-earnings ratio of 71.75 and a beta of 1.01. ZELTIQ Aesthetics has a one year low of $19.95 and a one year high of $56.18.

This article was originally posted by sleekmoney and is the property of of sleekmoney. If you are reading this article on another publication, it was copied illegally and republished in violation of U.S. and international trademark & copyright law. The correct version of this article can be read at http://sleekmoney.com/zeltiq-aesthetics-inc-zltq-rating-lowered-to-neutral-at-piper-jaffray-companies/1661603.html.

In other ZELTIQ Aesthetics news, VP Carl Lamm sold 21,600 shares of the company’s stock in a transaction on Thursday, December 8th. The shares were sold at an average price of $45.00, for a total transaction of $972,000.00. Following the transaction, the vice president now owns 34,208 shares in the company, valued at $1,539,360. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Mark J. Foley sold 10,000 shares of the company’s stock in a transaction on Tuesday, December 13th. The stock was sold at an average price of $44.08, for a total transaction of $440,800.00. Following the transaction, the insider now owns 252,439 shares in the company, valued at approximately $11,127,511.12. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 57,600 shares of company stock worth $2,535,120. Corporate insiders own 15.60% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. New York State Teachers Retirement System increased its stake in shares of ZELTIQ Aesthetics by 0.4% in the second quarter. New York State Teachers Retirement System now owns 47,852 shares of the company’s stock valued at $1,308,000 after buying an additional 200 shares in the last quarter. Riverbridge Partners LLC increased its stake in shares of ZELTIQ Aesthetics by 14.2% in the second quarter. Riverbridge Partners LLC now owns 1,166,362 shares of the company’s stock valued at $31,877,000 after buying an additional 144,781 shares in the last quarter. New Jersey Better Educational Savings Trust increased its stake in shares of ZELTIQ Aesthetics by 22.2% in the second quarter. New Jersey Better Educational Savings Trust now owns 22,000 shares of the company’s stock valued at $601,000 after buying an additional 4,000 shares in the last quarter. Handelsinvest Investeringsforvaltning increased its stake in shares of ZELTIQ Aesthetics by 135.0% in the second quarter. Handelsinvest Investeringsforvaltning now owns 23,500 shares of the company’s stock valued at $642,000 after buying an additional 13,500 shares in the last quarter. Finally, Nationwide Fund Advisors increased its stake in shares of ZELTIQ Aesthetics by 12.2% in the second quarter. Nationwide Fund Advisors now owns 23,254 shares of the company’s stock valued at $636,000 after buying an additional 2,527 shares in the last quarter.

About ZELTIQ Aesthetics

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

5 Day Chart for NASDAQ:ZLTQ

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/zeltiq-aesthetics-inc-zltq-rating-lowered-to-neutral-at-piper-jaffray-companies/1661603.html

Receive News & Ratings for ZELTIQ Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZELTIQ Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *